Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Cash: 2019-2025

Historic Change in Cash for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to -$5.8 million.

  • Benitec Biopharma's Change in Cash fell 115.74% to -$5.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $46.9 million, marking a year-over-year decrease of 3.12%. This contributed to the annual value of $46.9 million for FY2025, which is 3.12% down from last year.
  • Latest data reveals that Benitec Biopharma reported Change in Cash of -$5.8 million as of Q2 2025, which was down 122.88% from $25.3 million recorded in Q1 2025.
  • In the past 5 years, Benitec Biopharma's Change in Cash ranged from a high of $36.8 million in Q2 2024 and a low of -$6.2 million during Q1 2024.
  • Its 3-year average for Change in Cash is $8.7 million, with a median of $3.2 million in 2023.
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 158.72% in 2022, then spiked by 1,002.40% in 2024.
  • Quarterly analysis of 5 years shows Benitec Biopharma's Change in Cash stood at -$3.4 million in 2021, then tumbled by 76.46% to -$6.0 million in 2022, then increased by 8.46% to -$5.5 million in 2023, then soared by 290.20% to $10.4 million in 2024, then crashed by 115.74% to -$5.8 million in 2025.
  • Its Change in Cash was -$5.8 million in Q2 2025, compared to $25.3 million in Q1 2025 and $10.4 million in Q4 2024.